Task: Answer the multiple-choice question.
Question: Which compound exhibits a 17.217% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CN(C)C(=O)CCC(=O)N1CCCC(N2CCN(c3cccc(C(F)(F)F)c3)CC2)C1
b. COc1ccc(C(=O)NC(=S)N(C)C2CCCCC2)cc1Br
c. COc1ccc(OC)c(NC(=O)c2nnn(CC(=O)Nc3ccc4c(c3)OCO4)c2N)c1
Answer: b. COc1ccc(C(=O)NC(=S)N(C)C2CCCCC2)cc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C(=O)NC(=S)N(C)C2CCCCC2)cc1Br
COc1ccc(C(=O)NC(=S)N(C)C2CCCCC2)cc1Br
3-bromo-N-[cyclohexyl(methyl)carbamothioyl]-4-methoxybenzamide